BULLFROG AI HOLDINGS, INC. Increase (Decrease) in Prepaid Expense and Other Assets
BULLFROG AI HOLDINGS, INC. (BFRG) reported Increase (Decrease) in Prepaid Expense and Other Assets of $144.04 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-14
- BULLFROG AI HOLDINGS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was $102.36K.
- BULLFROG AI HOLDINGS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was $41.68K, a 75.27% decline year-over-year.
- BULLFROG AI HOLDINGS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was -$179.11K.
- BULLFROG AI HOLDINGS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was $50.69K.
- BULLFROG AI HOLDINGS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2025 was -$11.19K.
- BULLFROG AI HOLDINGS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2024 was -$34.28K.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $102.36K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $144.04K 10-Q · filed 2026-08-14 | -$35.08K derived: sum of 3 quarters · filed 2026-08-14 | $15.61K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $41.68K 10-Q · filed 2026-05-14 | -$137.44K derived: sum of 2 quarters · filed 2026-05-14 | -$86.75K derived: sum of 3 quarters · filed 2026-05-14 | -$138.04K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | -$179.11K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | -$128.43K derived: sum of 2 quarters · filed 2026-03-19 | -$179.71K derived: sum of 3 quarters · filed 2026-08-14 | -$11.19K 10-K · filed 2026-03-19 |
| 2025-09-30 | $50.69K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$601.00 derived: sum of 2 quarters · filed 2026-08-14 | $167.93K 10-Q · filed 2025-11-14 | -$79.01K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | -$51.29K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $117.24K 10-Q · filed 2026-08-14 | -$129.70K derived: sum of 3 quarters · filed 2026-08-14 | |
| 2025-03-31 | $168.53K 10-Q · filed 2026-05-14 | -$78.41K derived: sum of 2 quarters · filed 2026-05-14 | ||
| 2024-12-31 | -$246.94K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | -$34.28K 10-K · filed 2026-03-19 | ||
| 2024-09-30 | $212.66K 10-Q · filed 2025-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B |